Literature DB >> 8166962

The use of Bacillus subtilis as an antidiarrhoeal microorganism.

P Mazza1.   

Abstract

This review describes the therapeutic activity of Bacillus subtilis spores (Enterogermina) in the treatment of intestinal disorders associated with alterations in the qualitative and quantitative composition of the normal human intestinal flora. On the basis of the present knowledge of gastrointestinal microbiology and of the physiology fo this antidiarrhoeal microorganism, a mechanism of action of oral bacteriotherapy with B. subtilis is proposed. Advantages of the use of B. subtilis as an antidiarrhoeal microorganism are also discussed.

Entities:  

Mesh：

Year:  1994        PMID： 8166962

Source DB:  PubMed          Journal:  Boll Chim Farm        ISSN： 0006-6648


  32 in total

1.  Bacterial spores as vaccine vehicles.

Authors:  Le H Duc; Huynh A Hong; Neil Fairweather; Ezio Ricca; Simon M Cutting
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders.

Authors:  N T Hoa; L Baccigalupi; A Huxham; A Smertenko; P H Van; S Ammendola; E Ricca; A S Cutting
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

3.  Physicochemical, microbiological and spoilage analysis of probiotic processed cheese analogues with reduced emulsifying salts during refrigerated storage.

Authors:  Sheida Ehsannia; Mohammad Reza Sanjabi
Journal:  J Food Sci Technol       Date:  2016-01-06       Impact factor: 2.701

4.  Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy.

Authors:  S Senesi; F Celandroni; A Tavanti; E Ghelardi
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

5.  Macrophages Are Phenotypically and Functionally Diverse across Tissues in Simian Immunodeficiency Virus-Infected and Uninfected Asian Macaques.

Authors:  Alexandra M Ortiz; Sarah R DiNapoli; Jason M Brenchley
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

Review 6.  Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier.

Authors:  Na-Kyoung Lee; Won-Suck Kim; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2019-10-08       Impact factor: 2.391

7.  In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

Authors:  I V Pinchuk; P Bressollier; B Verneuil; B Fenet; I B Sorokulova; F Mégraud; M C Urdaci
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

8.  Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine.

Authors:  Guangyu Zhao; Yu Miao; Yan Guo; Hongjie Qiu; Shihui Sun; Zhihua Kou; Hong Yu; Junfeng Li; Yue Chen; Shibo Jiang; Lanying Du; Yusen Zhou
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Administration of Bacillus coagulans in calves: recovery from faecal samples and evaluation of functional aspects of spores.

Authors:  Barbara Ripamonti; Alessandro Agazzi; Antonella Baldi; Claudia Balzaretti; Carla Bersani; Silvia Pirani; Raffaella Rebucci; Giovanni Savoini; Simone Stella; Alberta Stenico; Cinzia Domeneghini
Journal:  Vet Res Commun       Date:  2009-09-18       Impact factor: 2.459

10.  Immunogenicity of self-adjuvanticity oral vaccine candidate based on use of Bacillus subtilis spore displaying Schistosoma japonicum 26 KDa GST protein.

Authors:  Li Li; Xuchu Hu; Zhongdao Wu; Shiqiu Xiong; Zhenwen Zhou; Xiaoyun Wang; Jin Xu; Fangli Lu; Xinbing Yu
Journal:  Parasitol Res       Date:  2009-09-16       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.